
08 Feb 2012
Pirate Queen West End production, in aid of Leukaemia UK
In February 2020, theatre producer Tom Gribby brought together an impressive cast for The Pirate Queen production at the London Coliseum, helping raise more than £10,000 for our cause
Tom Gribby chose Leukaemia UK as the beneficiary of this production as it is a cause close to this heart, having experienced someone close to him being affected by leukaemia.
The score, by Claude-Michel Schönberg and Alain Boublil, steeped in Irish traditions and powerful ballads, The Pirate Queen set the scene in 16th Century Ireland and starred an impressive cast which included Hannah Waddingham, Rachel Tucker, Jai McDowall & Matt Pagan to name but a few.
We are grateful to Tom Gribby for supporting our cause and extend our gratitude to all those who contributed towards this production as well as the audience.
At the cheque presentation, Chris Corbin OBE, Chairman of Leukaemia UK Trustees and a Director of Corbin & King, said: “Leukaemia UK is honoured to be the beneficiary of this magnificent production of The Pirate Queen. We are grateful for this generous £10,058 donation, especially during this challenging time, which will help us continue to fund our vital research and care projects. We extend our gratitude to Tom Gribby and all those involved, this kind contribution will help us make a difference to those affected by leukaemia and other blood cancers.”
Tom Gribby, theatre producer, (pictured, left) said:
I am delighted at the amount raised from the Pirate Queen UK Premiere concert earlier this year, to support and highlight the incredible work that Leukaemia UK do; a cause that is very close to my heart. My producing debut at the West End’s largest theatre was no mean feat, and would not have at all been possible without the constant support of Claude-Michel and Alain, the creative team, cast and choir, musicians, technical team, Coliseum team, all at Leukaemia UK and, of course, the audience that made the atmosphere at the one night gala simply electric.”
Little did we know back in February how our lives would be affected by COVID-19, with the lockdown and all of us having to adhere to social distancing guidelines to stay safe. As with many other industries, theatres have been affected by these guidelines and remain closed. This made the receipt of this £10,058 donation even more significant and humbling.
If you have been inspired by Tom’s efforts, we would welcome you getting involved in supporting our cause. You can donate, take part in an event or if you have a particular fundraising idea of initiative and want to speak to us about is, do get in touch by completing this form.
Read more stories from our community.
Related posts
18 November 2024
Leukaemia UK’s Patient Care Pioneer Award fuels innovative research to revolutionize ‘watch and wait’ approach
Leukaemia UK is excited to announce Professor Francesco Forconi from University Hospital Southampton (UHS) as the first recipient of its Patient Care Pioneer Award. Through this new funding initiative, Professor…
25 June 2019
Championing groundbreaking therapies and emotional support
We are proud to be at the forefront of funding innovative research into gene therapy treatments
4 June 2022
Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel
Leukaemia UK is committed to championing advancements in better treatments and care for all. We want to ensure the needs of patients are at the heart of everything we do, and that the voices of people affected by leukaemia and related conditions are being heard. That is why we are setting up a Patient Experience Advisory Panel.
10 November 2021
An urgent call from One Cancer Voice group of cancer charities for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival & care
Leukaemia UK has joined with 50 other cancer charities in writing to the Prime Minister, Chancellor of the Exchequer and Secretary of State for Health and Social Care. We are calling on the Government to urgently deliver on commitments to improve cancer survival and care in the forthcoming Spending Review.